XML 42 R17.htm IDEA: XBRL DOCUMENT
v3.22.0.1

SHARE-BASED COMPENSATION | 12 Months Ended
--- | ---
Dec. 31, 2021
Share-based Payment Arrangement [Abstract] |
Share-based Payment Arrangement [Text Block] | NOTE 9 - STOCKHOLDERS’ EQUITY, EMPLOYEE BENEFIT PLANS AND SHARE-BASED COMPENSATION Shelf Registration In December 2020, we completed an underwritten public offering of 2,990 shares of our common stock at a public offering price of $7.25. We realized gross proceeds of $21,700 before deducting underwriting discounts and estimated offering expenses. In March 2021, we filed a universal shelf registration statement on Form S-3 with the Securities and Exchange Commission (“SEC”) to provide access to additional capital, if needed. Pursuant to the shelf registration statement, we may from time to time offer to sell in one or more offerings shares of our common stock or other securities having an aggregate value of up to $150,000 (which includes $1,480 of unsold securities that were previously registered on other registration statements effective at the time of this filing of our current S-3). The shelf registration statement relating to these securities became effective on April 21, 2021. As of December 31, 2021, there is $150,000 remaining available under the shelf registration statement. Also in March 2021, we filed an acquisition shelf registration statement on Form S-4 with the Securities and Exchange Commission (“SEC”) to allow for us to issue securities in future business combinations, Pursuant to the acquisition shelf registration statement, we may from time to time issue up to 12,500 shares of our common stocks as consideration in future business combinations. The shelf registration statement relating to these securities became effective on April 21, 2021. As of December 31, 2021, there are 12,500 shares of common stock available for issuance under this acquisition shelf registration statement. Share Repurchase Program On March 10, 2020, our Board of Directors authorized a new stock repurchase plan, under which we may repurchase up to $5,000 of our outstanding common stock. This new stock repurchase program is in addition to the 364 shares available under our existing stock repurchase plan. Under this new stock repurchase program, we may repurchase shares in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The extent to which we repurchase our shares, and the timing of such repurchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other corporate considerations, as determined by our management. The repurchase program may be extended, suspended or discontinued at any time. We expect to finance the program from existing cash resources. Stock and Stock Option Plans We have one active equity plan, the 2018 Incentive Award Plan (the “2018 Plan”). The 2018 Plan, approved by our shareholders, replaced our 2009 Equity Incentive Plan, as amended (the “2009 Plan”), however, the terms and conditions of the 2009 Plan will continue to govern any outstanding awards granted thereunder. Employees and consultants of the Company, its subsidiaries and affiliates, as well as members of our board, are eligible to receive awards under the 2018 Plan. The 2018 Plan provides for the grant of stock options, including incentive stock options (“ISOs”) and nonqualified stock options (“NQSOs”), stock appreciation rights, restricted stock, restricted stock units ("RSUs"), performance bonus awards, performance stock unit awards, other stock or cash-based awards and dividend equivalents to eligible individuals. We generally grant stock options with exercise prices equal to the fair market value at the time of grant. The options generally vest over three to four years and are exercisable for a period of five to ten years beginning with the date of grant. The number of shares available for issuance under the 2018 Plan is equal to the sum of (i) 2,350 shares, and (ii) any shares subject to issued and outstanding awards under the 2009 Plan as of the effective date of the 2018 Plan that expire, are canceled or otherwise terminate following the effective date of the 2018 Plan. We have 1,958 options and RSUs granted and outstanding pursuant to the 2018 Plan as of December 31, 2021. Currently, the number of shares available for issuance under the 2018 Plan is equal to the sum of (i) 2,350 shares, and (ii) any shares subject to issued and outstanding awards under the 2009 Plan as of the effective date of the 2018 Plan that expire, are cancelled or otherwise terminate following the effective date of the 2018 Plan. In December 2019, we offered to exchange certain outstanding options to purchase shares of our common stock previously granted under the 2009 Plan and the 2018 Plan that have an exercise price per share higher than the greater of $8.50 or the closing trading price of our common stock on the offer expiration date (“eligible options”) for new RSUs to be granted under the 2018 Plan. The offer exchange program was approved by our board of directors and by our shareholders earlier in 2019. Under the offer exchange program, every 2.5 shares underlying an eligible option would be exchanged for one new RSU. Upon expiration of the exchange offer in January 2020, we granted 187 RSUs in exchange for the cancellation of options to purchase 468 shares that were tendered by employees who participated in the offer exchange program. We use the Black-Scholes option valuation model to value employee stock awards. We estimate stock price volatility based upon our historical volatility. Estimated option life and forfeiture rate assumptions are derived from historical data. For stock-based compensation awards with graded vesting, we recognize compensation expense using the straight-line amortization method. Total compensation expense recognized in the Consolidated Statements of Comprehensive Income (Loss) for stock based awards was $2,990 and $2,365 for 2021 and 2020, respectively. The following table summarizes the weighted average assumptions used to develop their fair value for the years ending December 31:
| 2021 |  | 2020
Grant date fair value | $ | 3.63 |  |  | $ | 2.44 |
Risk-free interest rate | 0.64 | % |  | 0.20 | %
Expected volatility | 61 | % |  | 55 | %
Expected life | 3.99 years |  | 2.85 years
Dividend yield | — |  |  | — |
As of December 31, 2021, we reserved shares of common stock for future issuance under the 2009 Plan and 2018 Plan as follows (in thousands):
Options and RSUs outstanding | 2,110 |
Shares available for future grant | 604 |
Shares reserved | 2,714 |
The following table summarizes activity related to options during the year ended December 31, 2021:
| Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term |  | Aggregate Intrinsic Value
Outstanding, beginning of year | 1,245 |  |  | $ | 7.89 |  |  |  |  |
Granted | 1,187 |  |  | 7.90 |  |  |  |  |
Exercised | (61) |  |  | 6.41 |  |  |  |  |
Cancelled | (478) |  |  | 7.19 |  |  |  |  |
Outstanding, end of year | 1,893 |  |  | $ | 8.03 |  |  | 3.49 |  | $ | 900 |
Vested and expected to vest | 1,652 |  |  | $ | 8.06 |  |  | 3.36 |  | $ | 842 |
Exercisable | 608 |  |  | $ | 8.70 |  |  | 2.06 |  | $ | 469 |
The total intrinsic value of options exercised during the years ended December 31, 2021 and 2020 was $110 and $205, respectively. As of December 31, 2021, total compensation cost not yet recognized related to nonvested share options was $3,771, which is expected to be recognized over a weighted average period of 2.29 years. The following table summarizes activity related to RSUs during the year ended December 31, 2021 (in thousands, except for weighted average grant date fair value):
| Shares |  | Weighted Average Grant Date Fair Value
Outstanding, beginning of year | 425 |  |  | $ | 5.94 |
Granted | 118 |  |  | 8.16 |
Released | (176) |  |  | 6.08 |
Forfeited | (150) |  |  | 5.75 |
Outstanding, end of year | 217 |  |  | $ | 7.17 |
The total fair value of RSUs vested during the years ended December 31, 2021 and 2020 was $1,507 and $528, respectively. As of December 31, 2021, total compensation cost net yet recognized related to nonvested RSUs was $1,485, which is expected to be recognized over a weighted average period of 1.78 years. As of December 31, 2021, we had 604 shares available for grant pursuant to the 2018 Plan. 401(k) Savings Plan We sponsor a defined contribution 401(k) plan that is available to substantially all employees. Our Board of Directors may amend or terminate the plan at any time. We provided matching contributions to the plan of $261 and $124 in December 31, 2021 and 2020, respectively. Employee Stock Purchase Plan Our Employee Stock Purchase Plan (“Purchase Plan”) was approved by the shareholders in June 2017. The Purchase Plan allows all eligible employees to purchase a limited number of shares of our common stock during pre-specified offering periods at a discount established by the Board of Directors, not to exceed 15% of the fair market value of the common stock, at the beginning or end of the offering period (whichever is lower). Under the ESPP, 475 shares were reserved for issuance of which there remains 308 shares available for future issuance.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration